PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
RDY vs. SSO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

RDY vs. SSO

Last updated Jul 17, 2026
Documentation

RDY (Dr. Reddy's Laboratories Limited) is a stock, while SSO (ProShares Ultra S&P500) is Leveraged Equities fund tracking the S&P 500. Over the past 10 years, RDY returned 2.46%/yr vs 23.26%/yr for SSO. At a 0.36 correlation, their price movements are largely independent.

Performance

RDY vs. SSO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dr. Reddy's Laboratories Limited (RDY) and ProShares Ultra S&P500 (SSO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RDY achieves a -9.54% return, which is significantly lower than SSO's 17.80% return. Over the past 10 years, RDY has underperformed SSO with an annualized return of 2.46%, while SSO has yielded a comparatively higher 23.26% annualized return.

RDY

1D
-0.55%
1M
-4.51%
6M
-2.98%
YTD
-9.54%
1Y
-12.53%
3Y*
0.81%
5Y*
-1.69%
10Y*
2.46%

SSO

1D
-1.03%
1M
0.06%
6M
14.60%
YTD
17.80%
1Y
37.75%
3Y*
32.35%
5Y*
18.24%
10Y*
23.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RDY vs. SSO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
RDY
Dr. Reddy's Laboratories Limited		-9.54%-10.53%14.13%36.47%-19.74%-7.33%76.80%8.45%0.37%-16.46%
SSO
ProShares Ultra S&P500		17.80%26.19%43.48%46.65%-38.98%60.57%21.54%63.45%-14.60%44.35%

Correlation

The correlation between RDY and SSO is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jun 21, 2006

0.36

Over the past year, the correlation between RDY and SSO has dropped to 0.13 - well below their long-term average of 0.36, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Dr. Reddy's Laboratories Limited

ProShares Ultra S&P500

Often compared with RDY:
RDY vs. NATCOPHARM.NSRDY vs. HLNRDY vs. IBNRDY vs. ABBVRDY vs. JNJRDY vs. HDRDY vs. DRREDDY.NS
Often compared with SSO:
SSO vs. QLDSSO vs. SPYSSO vs. UPROSSO vs. VOOSSO vs. SPUUSSO vs. SPXLSSO vs. QQQ

Return for Risk

RDY vs. SSO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
RDY
RDY Risk / Return Rank: 1717
Overall Rank
RDY Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
RDY Sortino Ratio Rank: 2121
Sortino Ratio Rank
RDY Omega Ratio Rank: 2121
Omega Ratio Rank
RDY Calmar Ratio Rank: 1616
Calmar Ratio Rank
RDY Martin Ratio Rank: 33
Martin Ratio Rank
SSO
SSO Risk / Return Rank: 5454
Overall Rank
SSO Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
SSO Sortino Ratio Rank: 5151
Sortino Ratio Rank
SSO Omega Ratio Rank: 5252
Omega Ratio Rank
SSO Calmar Ratio Rank: 5151
Calmar Ratio Rank
SSO Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDY vs. SSO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and ProShares Ultra S&P500 (SSO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

RDYSSODifference
Sharpe ratioReturn per unit of total volatility
-0.49
1.52

-2.01

Sortino ratioReturn per unit of downside risk
-0.54
2.05

-2.58

Omega ratioGain probability vs. loss probability

0.93

1.27

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.72

2.09

-2.81

Martin ratioReturn relative to average drawdown

-1.68

8.58

-10.26

RDY vs. SSO - Sharpe Ratio Comparison

The current RDY Sharpe Ratio is -0.49, which is lower than the SSO Sharpe Ratio of 1.52. The chart below compares the historical Sharpe Ratios of RDY and SSO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Drawdowns

RDY vs. SSO - Drawdown Comparison

The maximum RDY drawdown since its inception was -60.62%, smaller than the maximum SSO drawdown of -84.67%. Use the drawdown chart below to compare losses from any high point for RDY and SSO.

Loading charts...

Drawdown Indicators

RDYSSODifference

Max Drawdown

Largest peak-to-trough decline

-60.62%

-84.67%

+24.05%

Max Drawdown (1Y)

Largest decline over 1 year

-17.43%

-18.17%

+0.74%

Max Drawdown (3Y)

Largest decline over 3 years

-26.61%

-35.21%

+8.60%

Max Drawdown (5Y)

Largest decline over 5 years

-33.54%

-46.73%

+13.19%

Max Drawdown (10Y)

Largest decline over 10 years

-47.13%

-59.34%

+12.21%

Current Drawdown

Current decline from peak

-24.12%

-2.70%

-21.42%

Average Drawdown

Average peak-to-trough decline

-21.90%

-19.48%

-2.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.47%

4.41%

+3.06%

Volatility

RDY vs. SSO - Volatility Comparison

Dr. Reddy's Laboratories Limited (RDY) has a higher volatility of 12.17% compared to ProShares Ultra S&P500 (SSO) at 6.83%. This indicates that RDY's price experiences larger fluctuations and is considered to be riskier than SSO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

RDYSSODifference

Volatility (1M)

Calculated over the trailing 1-month period

12.17%

6.83%

+5.34%

Volatility (6M)

Calculated over the trailing 6-month period

20.56%

19.92%

+0.64%

Volatility (1Y)

Calculated over the trailing 1-year period

25.45%

25.02%

+0.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.80%

33.87%

-10.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

26.74%

35.86%

-9.12%

Dividends

RDY vs. SSO - Dividend Comparison

RDY's dividend yield for the trailing twelve months is around 0.72%, more than SSO's 0.67% yield.

PositionTTM20252024202320222021202020192018201720162015
RDY
Dr. Reddy's Laboratories Limited		0.72%0.65%0.60%1.39%1.48%1.04%0.46%0.71%0.00%0.78%0.62%0.63%
SSO
ProShares Ultra S&P500		0.67%0.68%0.85%0.18%0.50%0.18%0.20%0.50%0.75%0.39%0.51%0.63%

Frequently Asked Questions

RDY and SSO have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RDY has higher volatility (12.17%) compared to SSO (6.83%). In terms of maximum drawdown, RDY dropped -60.62% vs SSO's -84.67%.

SSO currently has the higher Sharpe Ratio (1.52 vs -0.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RDY and SSO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer